A Novel Community-Based Strategy (Self-Sampling HPV Testing) to Improve Access to Cervical Cancer Screening in the Rio Grande Valley of Texas, the Prevencion en sus Manos Trial

This clinical trial evaluates the impact of self-sampling human papillomavirus virus (HPV) testing on cervical cancer screening in the Rio Grande Valley (RGV) of Texas. Cervical cancer may be preventable through vaccination against the virus that causes it, HPV, and through screening. Screening tests, including the Papanicolaou (Pap) smear and testing for HPV, are effective in identifying those at higher risk for developing cancer. However, many people do not have access to these tests because a pelvic exam with a healthcare provider is required. Self-sampling, collecting one's own sample, for HPV testing has been shown to work as well as sampling performed by a healthcare provider and may be an effective way to increase participation in screening for cervical cancer in the RGV of Texas.

Additional locations may be listed on ClinicalTrials.gov for NCT06109870.

Trial PhaseNo phase specified

Trial Typescreening

Lead OrganizationM D Anderson Cancer Center

Principal InvestigatorJane Richards Montealegre

• Primary ID2023-0529
• Secondary IDsNCI-2023-09607
• ClinicalTrials.gov IDNCT06109870